GeneQuine Biotherapeutics Changes Name to GQ Bio Therapeutics, Expands Facilities and Appoints Industry Veteran to Board. The company is also sharpening its R&D focus on its high-capacity gene therapy vector platform and the development of gene therapies for prevalent diseases
63
@GeneQuineBio Selects @ExotheraWorld to Support the Next Stage of Its Osteoarthritis Gene Therapy Development bit.ly/3lawC9J #healthcare #Biontech
1
GeneQuine Appoints Big Pharma Veteran Bernhard Kirschbaum to its Advisory Board. Dr. Kirschbaum, who will chair the board, has 20 years experience in R&D of big pharma companies, and was in his last position EVP Global Research & Early Development and board member at Merck Serono
ALT GeneQuine Appoints Big Pharma Veteran Bernhard Kirschbaum to its Advisory Board
2
@GeneQuineBio Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance #Genetherapy Pipeline for Musculoskeletal Diseases
read more: t1p.de/ibfa
Europe grants Patent for @GeneQuineBio Lead Product.
The European Patent Office grants Patent covering GeneQuine’s lead #genetherapy candidate GQ-303 for treatment of #osteoarthritis. The patent protects bit.ly/3e3AhSs
3
GeneQuine Adds World Renowned Osteoarthritis Key Opinion Leader Prof. @Yves Henrotin to Advisory Board. GeneQuine Biotherapeutics developing gene therapy for osteoarthritis and other musculoskeletal disorders is pleased to name the… Read more: bit.ly/2FJwB8B
1
The European Patent Office issued an intention to grant notice for patent application no. 14 708 933.8 – 1120, covering @GeneQuineBio lead #GeneTherapy candidate GQ-303 for treatment of #osteoarthritis.
The patent protects bit.ly/2Djvf30
2
Congratulations to @FlexionInc for IND Clearance by FDA and Phase 1 Study Initiation of FX201, a #GeneTherapy Candidate for #Osteoarthritis, Triggering a Milestone Payment to @GeneQuineBio bit.ly/2q7xIur
3
US Patent Covering #genetherapy Drug Candidates for Treatment of #OA issued. The USPTO grants a patent for FX201 (@GeneQuineBio’s former drug candidate GQ-203, acquired by Flexion Therapeutics, Inc.) and veterinary analogs for treatment of osteoarthritis. genequine.com/en/news/articl…
@GeneQuineBio Receives Non-Dilutive Funding for Setting Up and Expanding R&D Site. The grant supports acquisition of state-of-the-art equipment for preclinical research and #genetherapy vector production.
@GeneQuineBio has set up a #lab in the greater Berlin area and started R&D activities at this site. In this facility, GeneQuine will conduct preclinical research, generate & produce #genetherapy vectors for development of #newproduct candidates,and optimize large-scale production
GQ Bio retweeted
The @ArthritisFdn says #Osteoarthritis is the most common type of #arthritis. Here is how one #advancebiotechgrant winner is using #genetherapy to improve mobility. ms.spr.ly/6010T8j16
GQ Bio retweeted
Kilian Guse @GeneQuineBio “#Speed of maturing #bioetch company and hence money and great team is #essential. You are simply sooner at the #point to know ‘is it gonna work or not.’” #advancebiotechgrant – at Darmstadt, Germany
GQ Bio retweeted
Therese Liechtenstein, #MVentures “There are tons of #biotechs, we #scout actively. We reach out to tech-transfer-office, run #incubator, but are also approached by the #companies themselves.” – at Darmstadt, Germany
GQ Bio retweeted
Expert forum kicked off right now at #advancebiotechgrant - lead by @DominAHR of @TPHeidelberg starting with the question “what is a #biotech company?”
@GeneQuineBio on Expert Panel Discussion @Merck_lifesci Advance #Biotech Grant Program Award Ceremony and how the grant accelerated GeneQuine's development of a novel #genetherapy platform & supported the lead program in #osteoarthritis. #MerckAccelerator genequine.com/en/news/articl…
@GeneQuineBio and collaborators published preclinical results from osteoarthritis gene therapy studies in leading, peer-reviewed arthritis journal. The data suggest symptomatic and disease-modifying efficacy in the treatment of osteoarthritis. onlinelibrary.wiley.com/doi/…
2
Positive Data on #Osteoarthritis Gene Therapy Generated by @GeneQuineBio and Collaborators Presented at #OARSI World Congress. genequine.com/en/news/articl…
1
@GeneQuineBio to attend Biopartnering and Investment Conference @biotrinity in London April 23 – 25, 2018. Meet GeneQuine’s CEO Kilian Guse genequine.com/en/news/articl…
2
@GeneQuineBio Featured on Leading Animal Health News Platform @animalpharm. GeneQuine's CEO was interviewed by @animalpharm regarding the company's partnering strategy for osteoarthritis product candidates for horses and dogs.
goo.gl/6nbvjn
